The active substance is 500mg as mycophenolate mofetil. The other ingredients are : cellulose microcrystalline, povidone, hydroxypropyl cellulose, croscarmellose sodium, talc, magnesium stearate.
Mycophenolic acid (MPA), also known as mycophenolate, is an immunosuppressant medication indicated for the:
Organ transplant: prevention of organ transplant rejection. Mycophenolate mofetil is indicated for the prevention of organ transplant rejection in adults and kidney transplantation rejection in children over 2 years; whereas mycophenolate sodium is indicated for the prevention of kidney transplant rejection in adults. Mycophenolate sodium has also been used for the prevention of rejection in liver, heart, or lung transplants in children older than two years.
Specifically, it is recommended to follow kidney, heart, and liver transplantation. It comes as mycophenolate mofetil and mycophenolate sodium.
Autoimmune disease: Mycophenolate is increasingly utilized as a steroid-sparing treatment in autoimmune diseases and similar immune-mediated disorders including Behçet’s disease, pemphigus vulgaris, immunoglobulin A nephropathy, small vessel vasculitis, and psoriasis.
Mycophenolate Mofetil or Mycophenolic acid should be taken orally at about the same time each day, either with or without food. Mycophenolate tablets should be swallowed whole with water. The tablets should not be opened, broken, or chewed.
Most common side effects of Mycophenolate or Cellcept include diarrhea, nausea, vomiting, joint pain; infections, leukopenia, anemia, fatigue, headache, cough, breathing issues, esophagitis, gastritis, gastrointestinal tract hemorrhage, invasive cytomegalovirus (CMV) infection, increased blood cholesterol levels, hypomagnesemia, hypocalcemia, hyperkalemia, and an increase in blood urea nitrogen (BUN) and latent viral infections.
Care should be exercised in the handling of CELLCEPT. CELLCEPT tablets should not be opened or crushed. Store permitted to 15°-30°C (59° to 86°F). Dispense in light-resistant containers.
The FDA approved this medicine in 1995 to prevent organ transplant rejection and its use in autoimmune diseases.
The active substance is 500mg as mycophenolate mofetil. The other ingredients are : cellulose microcrystalline, povidone, hydroxypropyl cellulose, croscarmellose sodium, talc, magnesium stearate.
Mycophenolate Mofetil Capsules and Mycophenolate Mofetil Tablets are indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants. Mycophenolate Mofetil Capsules and Mycophenolate Mofetil Tablets should be used concomitantly with cyclosporine and corticosteroids.
The active ingredient in the medicine is Mycophenolate Mofetil, and the inactive ingredients are croscarmellose sodium, magnesium stearate, povidone (K-90), and pregelatinized starch.
Here are the various strength of Mycophenolate tablets:
Patients can simply fill the order form or can send mail at info@ikrispharmanetwork.com. Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician
Do not crush the medicine.
Store the medicine at the temperature 15°-30°C (59° to 86°F).
All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Mycophenolate Mofetil is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.